- Nalfurafine
-
Nalfurafine Systematic (IUPAC) name (2E)-N-[(5α,6β)-17-(cyclopropylmethyl)- 3,14-dihydroxy- 4,5-epoxymorphinan- 6-yl]- 3-(3-furyl)- N-methylacrylamide Clinical data AHFS/Drugs.com International Drug Names Pregnancy cat. ? Legal status ? Routes intravenous Identifiers CAS number 152658-17-8 ATC code V03AX02 PubChem CID 6445230 IUPHAR ligand 1651 UNII XC41AVD567 Synonyms TRK-820 Chemical data Formula C28H32N2O5 Mol. mass 476.564 g/mol (what is this?) (verify) Nalfurafine (INN and USAN;[1] also known as AC-820, TRK-820; trade name Remitch) is a κ-opioid receptor agonist marketed as a treatment for uremic pruritus in people undergoing hemodialysis.[2]
As of January 2010[update], it is also being investigated for the treatment of pruritus in patients with chronic liver disease.[3]
References
This dermatologic drug article is a stub. You can help Wikipedia by expanding it.